Inflammatory bowel diseases (IBDs), represented by Crohn disease and ulcerative colitis,
are associated with major morbidity in Western countries and with increasing incidence in …

In this review, we provide an update on genome-wide association studies (GWAS) in
inflammatory bowel disease (IBD). In addition, we summarize progress in defining the …

Curcumin belongs to the family of natural compounds collectively called curcuminoids and it
possesses remarkable beneficial anti-oxidant, anti-inflammatory, anti-cancer, and …

Inflammatory bowel disease (IBD) is a group of chronic multifactorial disorders. According to
a recent study, the number of IBD association loci is increased to 201, of which 37 and 27 …

Crohn's disease and ulcerative colitis can be grouped as the inflammatory bowel diseases
(IBD). These conditions have become increasingly common in recent years, including in …

Autoimmune diseases represent a heterogeneous group of conditions whose incidence is
increasing worldwide. This has stimulated studies on their etiopathogenesis, derived from a …

Aim We evaluated the prevalence of apical periodontitis (AP) and the oral health status in
patients with inflammatory bowel diseases (IBDs) treated with immunomodulators, with …

Background Most cases of inflammatory bowel disease (IBD) are caused by complex host–
environment interaction. There are a number of conditions associated with a single-gene …

Hepatocyte nuclear 4 alpha (HNF4α), involved in glucose and lipid metabolism, has been
linked to intestinal inflammation and abnormal mucosal permeability. Moreover, in a …

Background The inflammatory bowel diseases (IBD) are common, complex disorders in
which genetic and environmental factors are believed to interact leading to chronic …